Nebraska Cancer Specialists is a clinical research site located in Omaha, Nebraska, United States 68130.
Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.
Nebraska Cancer Specialists has participated in 124 clinical trials with 61 currently active.
Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive, Hodgkin Disease.
Sponsors: Gilead Sciences, Seagen Inc., Pathos AI, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Omaha
Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Cancer Specialists has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Cancer Specialists has 124 clinical trials on record, with 61 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive, Hodgkin Disease.
Nebraska Cancer Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.